Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects.
Retlich S, Duval V, Ring A, Staab A, Hüttner S, Jungnik A, Jaehde U, Dugi KA, Graefe-Mody U. Retlich S, et al. Clin Pharmacokinet. 2010 Dec;49(12):829-40. doi: 10.2165/11536620-000000000-00000. Clin Pharmacokinet. 2010. PMID: 21053992 Clinical Trial.
Pharmacokinetics of linagliptin in subjects with hepatic impairment.
Graefe-Mody U, Rose P, Retlich S, Ring A, Waldhauser L, Cinca R, Woerle HJ. Graefe-Mody U, et al. Among authors: retlich s. Br J Clin Pharmacol. 2012 Jul;74(1):75-85. doi: 10.1111/j.1365-2125.2012.04173.x. Br J Clin Pharmacol. 2012. PMID: 22242621 Free PMC article.
Clinical pharmacokinetics and pharmacodynamics of linagliptin.
Graefe-Mody U, Retlich S, Friedrich C. Graefe-Mody U, et al. Among authors: retlich s. Clin Pharmacokinet. 2012 Jul 1;51(7):411-27. doi: 10.2165/11630900-000000000-00000. Clin Pharmacokinet. 2012. PMID: 22568694 Review.
15 results